Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | RGS12 | O14924 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL550790 | 1.00 | AOC3 (0.48) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL551822 | 1.00 | AOC3 (0.48) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL550791 | 1.00 | AOC3 (0.48) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL27825950 | 0.91 | TDP1 (0.50) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL5873439 | 0.91 | TDP1 (0.50) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL4077892 | 0.91 | TDP1 (0.50) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL30801376 | 0.91 | SLC6A2 (0.54) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| SCHEMBL117950 | 0.91 | SLC6A2 (0.54) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| Alcohol SCHEMBL28032136 | 0.86 | AOC3 (0.46) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 | |
| Bicarbonate SCHEMBL27926290 | 0.84 | SLC6A2 (0.48) | AOC3ALDH1A1KDM4ESLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2152771-B2 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON CATALYTIC CHEM IND (JP) | 2021-03-10 | — | — | EP | disclosed |
| EP-2152771-B1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON CATALYTIC CHEM IND (JP) | 2016-09-07 | — | — | EP | disclosed |
| US-8754264-B2 | Production method of unsaturated (poly)alkylene glycol ether monomer and production method of (poly)alkylene glycol chain-containing polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| CN-101657479-B | Method for producing unsaturated (poly) alkylene glycol ether monomer and method for producing (poly) alkylene glycol chain-containing polymer | NIPPON CATALYTIC CHEM IND | 2013-09-25 | — | — | CN | disclosed |
| CN-101331146-B | Analogs of alpha galactosylceramide and uses thereof | LUDWIG INST CANCER RES | 2012-06-13 | — | — | CN | disclosed |
| US-20100130793-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON SHOKUBAI CO. LTD (JP) | 2010-05-27 | — | — | US | disclosed |
| CN-101657479-A | Method for producing unsaturated (poly) alkylene glycol ether monomer and method for producing (poly) alkylene glycol chain-containing polymer | NIPPON CATALYTIC CHEM IND JP | 2010-02-24 | — | — | CN | disclosed |
| EP-2152771-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | Nippon Shokubai Co., Ltd. (JP) | 2010-02-17 | — | — | EP | disclosed |
| CN-101331146-A | Analogs of alpha galactosylceramide and uses thereof | LUDWIG INST CANCER RES (US) | 2008-12-24 | — | — | CN | disclosed |
| WO-2008126909-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130793-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | ALOX12, ALOX5, DECR2 | AOC3 1264/4885ALDH1A1 834/4885KDM4E 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.